Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
NCT06326411
- Conditions
- Glioma, MAPK Pathway Gene Mutation, MEK Mutation, +19 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- UCLA Hematology/Oncology Westwood, Los Angeles, California, United States
- Sarah Cannon Research Institute at Health ONE Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States